Role of Pharmaceutical Software in Vaccine Development and Manufacturing Process Optimization

Year : 2026 | Volume : 03 | Issue : 01 | Page : 1 8
    By

    Mohd. Wasiullah,

  • Piyush Yadav,

  • Aman Yadav,

  1. Principal, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  2. Head, Department of Pharmaceutical Chemistry, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  3. Scholar, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India

Abstract

Vaccine development and manufacturing have become increasingly complex due to the emergence of diverse vaccine platforms, stringent regulatory expectations, and global demand for safe and effective immunization. Across the vaccine lifecycle – from antigen design and preclinical evaluation to large‑scale manufacturing and post‑marketing surveillance – pharmaceutical software now plays a central role in handling data, optimizing processes, and ensuring regulatory compliance. Software tools support in silico antigen and epitope design, formulation optimization using design of experiments, management of clinical trial and pharmacovigilance data, and rigorous control of sterile manufacturing under current Good Manufacturing Practices (cGMP) and Quality by Design (QbD) frameworks. In industrial settings, systems, such as Manufacturing Execution Systems (MES), Enterprise Resource Planning (ERP), Quality Management Systems (QMS), Laboratory Information Management Systems (LIMS), and advanced analytics platforms, enable real‑time monitoring, batch traceability, predictive maintenance, and data‑driven decision making in vaccine production facilities. This article reviews key categories of pharmaceutical software, their functions, and their contribution to process optimization in vaccine development and manufacturing, highlighting how digital tools enhance efficiency, quality, and regulatory assurance while supporting rapid, scalable responses to infectious disease threats.

Keywords: CGMP, pharmaceutical software, process optimization, quality by design, vaccine development, vaccine manufacturing

[This article belongs to International Journal of Vaccines ]

How to cite this article:
Mohd. Wasiullah, Piyush Yadav, Aman Yadav. Role of Pharmaceutical Software in Vaccine Development and Manufacturing Process Optimization. International Journal of Vaccines. 2026; 03(01):1-8.
How to cite this URL:
Mohd. Wasiullah, Piyush Yadav, Aman Yadav. Role of Pharmaceutical Software in Vaccine Development and Manufacturing Process Optimization. International Journal of Vaccines. 2026; 03(01):1-8. Available from: https://journals.stmjournals.com/ijv/article=2026/view=241225


References

  1. El Arab RA, Alkhunaizi M, Alhashem YN, Al Khatib A, Bubsheet M, Hassanein S. Artificial intelligence in vaccine research and development: an umbrella review. Frontiers in immunology. 2025 May 8;16:1567116.
  2. Zafar S, Akhtar A, Sayed E, Onaiwu E, Arshad MS, Ahmad Z. Vaccine formulation design: challenges and opportunities. RSC Pharmaceutics. 2025;2(3):490-516..
  3. Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines—a new era in vaccinology. Nature reviews Drug discovery. 2018 Apr;17(4):261-79.
  4. Nair A, Kis Z. Bacteriophage RNA polymerases: catalysts for mRNA vaccines and therapeutics. Frontiers in Molecular Biosciences. 2024 Nov 21;11:1504876.
  5. Rathore AS, Winkle H. Quality by design for biopharmaceuticals. Nature biotechnology. 2009 Jan;27(1):26-34.
  6. Rathore AS, Bhambure R, Ghare V. Process analytical technology (PAT) for biopharmaceutical products. Analytical and bioanalytical chemistry. 2010 Sep;398(1):137-54.
  7. Isaksson AJ, Harjunkoski I, Sand G. The impact of digitalization on the future of control and operations. Computers & Chemical Engineering. 2018 Jun 9;114:122-9.
  8. Reinhardt IC, Oliveira JC, Ring DT. Current perspectives on the development of industry 4.0 in the pharmaceutical sector. Journal of Industrial Information Integration. 2020 Jun 1;18:100131.
  9. Su Q, Ganesh S, Moreno M, Bommireddy Y, Gonzalez M, Reklaitis GV, Nagy ZK. A perspective on Quality-by-Control (QbC) in pharmaceutical continuous manufacturing. Computers & Chemical Engineering. 2019 Jun 9;125:216-31.
  10. Thakkar S, Slikker Jr W, Yiannas F, Silva P, Blais B, Chng KR, Liu Z, Adholeya A, Pappalardo F, Soares MD, Beeler PE. Artificial intelligence and real-world data for drug and food safety–A regulatory science perspective. Regulatory Toxicology and Pharmacology. 2023 May 1;140:105388.
Regular Issue Subscription Review Article
Volume 03
Issue 01
Received 03/02/2026
Accepted 04/02/2026
Published 20/02/2026
Publication Time 17 Days
30

Login


My IP

PlumX Metrics